Interferon beta-1a Withdrawn Phase 4 Trials for Neuritis / Demyelinating Disorders / Optic Neuritis / Disseminated Sclerosis / Myelitis NOS Treatment

IndicationsStatusPurposePhase
WithdrawnTreatment4
clinicaltrials.gov IdentifierTitleDrugs
NCT00037115Induction Therapy With a Single High Dose Bolus of Intravenous Methotrexate With Leucovorin Rescue, Prior to Initiation of AVONEX® Treatment, in Patients Presenting With a First Acute Demyelinating Event.